This Breakthrough Therapy Designation highlights the impressive clinical benefit of Enhertu over the current standard of care
The study focused on patients without actionable genomic alterations whose disease had progressed after prior immunotherapy and platinum-based chemotherapy
According to IQVIA sales data for the 12-month period ending October 2025, the Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) market2 achieved annual sales of approximately $67.6 million
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
Xeureka will receive an upfront payment from UBE and will be eligible for milestone payments tied to future research progress
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
The company also reported significant progress toward its internally defined Sustainable Development Goals
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
Subscribe To Our Newsletter & Stay Updated
